Literature DB >> 4812251

[The beginning plasmacytoma].

H Brücher.   

Abstract

Mesh:

Substances:

Year:  1974        PMID: 4812251     DOI: 10.1007/bf01634378

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


× No keyword cloud information.
  32 in total

1.  EVOLUTION OF MULTIPLE MYELOMA.

Authors:  A R STEVENS
Journal:  Arch Intern Med       Date:  1965-01

2.  LONG-TERM SURVIVAL OF PATIENTS WITH MYELOMA OF THE VERTEBRAL COLUMN.

Authors:  D M COHEN; H J SVIEN; D C DAHLIN
Journal:  JAMA       Date:  1964-03-21       Impact factor: 56.272

3.  THE DEVELOPMENT OF A MYELOMA-LIKE CONDITION IN MINK WITH ALEUTIAN DISEASE.

Authors:  D D PORTER; F J DIXON; A E LARSEN
Journal:  Blood       Date:  1965-05       Impact factor: 22.113

4.  Plasmacytoma of lymph glands.

Authors:  M G NELSON; A R LYONS
Journal:  Cancer       Date:  1957 Nov-Dec       Impact factor: 6.860

5.  Transplantation of bone-marrow cells and fetal thymus in an infant with lymphopenic immunological deficiency.

Authors:  J De Koning; D W Van Bekkum; K A Dicke; L J Dooren; J Rádl; J J Van Rood
Journal:  Lancet       Date:  1969-06-21       Impact factor: 79.321

6.  Plasmacytoma of paranasal sinuses and nasal cavity.

Authors:  E B Castro; J S Lewis; E W Strong
Journal:  Arch Otolaryngol       Date:  1973-04

7.  Plasmacytoma of the upper air and food passages.

Authors:  L M Kotner; C C Wang
Journal:  Cancer       Date:  1972-08       Impact factor: 6.860

8.  [Successfully treated solitary plasmacytoma with paraproteinemia].

Authors:  G von Haehling
Journal:  Med Klin       Date:  1970-01-09

9.  Immunoglobulin synthesis and total body tumor cell number in IgG multiple myeloma.

Authors:  S E Salmon; B A Smith
Journal:  J Clin Invest       Date:  1970-06       Impact factor: 14.808

10.  Three cases of multiple myeloma in which the preclinical asymptomatic phases persisted throughout 15 to 24 years.

Authors:  O Norgaard
Journal:  Br J Cancer       Date:  1971-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.